Mississauga, Canada

Ling Wang

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Triumvira Immunologics USA, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ling Wang. Retrieved from https://idiyas.com/inventor/ling-wang-uux4qyuv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Inventor Ling Wang

Introduction

Ling Wang is a notable inventor based in Mississauga, Canada. She has made significant contributions to the field of immunology, particularly through her innovative work on T cell-antigen couplers.

Latest Patents

Ling Wang holds a patent for "Claudin 18.2 T cell-antigen couplers and uses thereof." This patent includes Claudin 18.2 T cell antigen couplers (TACs) polypeptides that possess an antigen-binding domain that binds Claudin 18.2, an antigen-binding domain that binds a protein associated with a TCR complex, and a T cell receptor signaling domain polypeptide. Additionally, nucleic acids encoding the Claudin 18.2 TACs are also provided. She has 1 patent to her name.

Career Highlights

Ling Wang is currently employed at Triumvira Immunologics USA, Inc. Her work focuses on advancing therapeutic strategies in immunology, showcasing her dedication to improving healthcare outcomes.

Collaborations

Some of her notable coworkers include Andreas Bader and Christopher W. Helsen. Their collaborative efforts contribute to the innovative research environment at Triumvira Immunologics.

Conclusion

Ling Wang's contributions to the field of immunology through her patent on Claudin 18.2 T cell-antigen couplers highlight her role as a leading inventor. Her work continues to pave the way for advancements in immunotherapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…